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Background: The intestinally located pancreatic enzyme, bile salt activated
lipase (BAL), possesses unique activities for digesting different kinds of lipids.
It also differs from other lipases in a requirement of bile salts for activity. A
structure-based explanation for these unique properties has not been reached
so far due to the absence of a three-dimensional structure. 
Results: The crystal structures of bovine BAL and its complex with
taurocholate have been determined at 2.8 Å resolution. The overall structure of
BAL belongs to the a / b hydrolase fold family. Two bile salt binding sites were
found in each BAL molecule within the BAL–taurocholate complex structure.
One of these sites is located close to a hairpin loop near the active site. Upon
the binding of taurocholate, this loop becomes less mobile and assumes a
different conformation. The other bile salt binding site is located remote from
the active site. In both structures, BAL forms similar dimers with the active
sites facing each other.
Conclusions: Bile salts activate BAL by binding to a relatively short ten-
residue loop near the active site, and stabilize the loop in an open
conformation. Presumably, this conformational change leads to the formation
of the substrate-binding site, as suggested from kinetic data. The BAL dimer
observed in the crystal structure may also play a functional role under
physiological conditions.
Introduction
Bile salt-activated lipase (BAL) is one of two lipases
secreted from the vertebrate pancreas into the intestine
for the digestion of fat [1]. In a few mammals, including
humans, BAL is also present in the milk to facilitate fat
absorption in infants [2,3]. Because of its wide range of
substrate reactivities, BAL has been documented with
several different names, including pancreatic carboxyl-
ester lipase, pancreatic cholesterol esterase, triacylglycerol
lipase, and lysophospholipase [1]. There is evidence to
support the importance of BAL for the absorption of
cholesterol, vitamin A and triacylglycerol. The hydrolytic
activity of BAL on naturally occurring lipids requires the
presence of bile salt. BAL also binds to heparin; this
binding has been shown to mediate cholesterol uptake in
cultured cells [4]. Transgenic mice without a functional
BAL have a reduced uptake of cholesterol ester [5].
Amino acid sequences of BAL from different species are
strongly homologous, particularly in the N-terminal
catalytic domain (residues 1–530 in human BAL) [1]. The
C-terminal region, or ‘C-tail’, (ca. residues 531–722 in
human BAL) has a mucin-like structure which is com-
prised of a different number of repeating units in BAL
from different species. The C-tail repeating unit consists
of 11 residues and is usually rich in proline, threonine and
serine residues. Some of the threonine residues of the C-
tail are O-glycosylated [6]. While human BAL has the
longest known C-tail of 16 repeating units, bovine BAL,
which consists of 579 residues [7], is among those having
shorter C-tails and its C-tail is not particularly proline-rich.
Salmon pancreatic BAL does not possess a C-tail at all [8]. 
Several crystal structures of lipases have been solved since
1990 [9–19]. A major common structural feature found in
these lipases is a core of mixed b sheet, of five to 14
strands, flanked by a helices. This secondary structure
forms the scaffold for the structure of the catalytic triad,
Ser-His-Asp/Glu, which was found to be essentially a
mirror image of the catalytic triad identified in serine pro-
teases of the trypsin family. These lipases belong to the
a /b hydrolase fold family [20]. A number of lipases and
some esterases, such as acetylcholinesterase, were further
grouped as a lipase/esterase family [21], based on the clear
homology in their primary sequences. Crystallography
studies showed that the catalytic triads in many of these
enzymes are buried beneath a flexible ‘lid’ structure. It
had been proposed that the active site becomes accessible
after a conformational change of this lid following the
interaction of the enzymes with a water–lipid interface
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[22]. This hypothesis is supported both by the fact that
many lipases are activated by such interfaces and that the
conformation of the lid actually varies in different crystal-
packing environments [11,17,18]. Movement of the lid at a
water–lipid interface is also deemed likely from modeling
studies [18].
The amino acid sequence of BAL, especially that of the
N-terminal half, is also clearly homologous with at least
four members of the lipase/esterase family whose crystal
structures have been elucidated: acetylcholinesterase from
Torpedo californica (TAChE) [23] and three fungal enzymes,
Geotrichum candidum lipase (GCL) [14], Candida rugose
lipase (CRL) [17] and Candida cylindracea cholesterol ester-
ase (CCE) [19]. Sequence alignment of BAL with these
four enzymes reveals about 30% amino acid residue iden-
tity [1], suggesting an even more significant tertiary struc-
tural similarity between BAL and other members of the
lipase/esterase family. The alignment also clearly shows
that BAL does not have the surface activation lid of other
lipases, such as CRL, indicating an absence of water–lipid
interfacial activation and perhaps suggesting a different
activation mechanism. As bile-salt activation is a unique
feature of the BAL family, it seems reasonable to hypo-
thesize that the bile-salt activation of BAL is conforma-
tionally related to the activation of other lipases by a
water–lipid interface.
Because of its nutritional importance and the availability
of homologous structures, the structure of BAL has been
studied using three-dimensional structure prediction and
molecular modeling [8,24]. The determination of its crys-
tal structure, however, has not been successful until now,
owing to the heterogeneity of glycosylation and a predic-
ted high conformational flexibility in the C-tail of the
enzyme. We report here crystal structures of BAL from
bovine pancreas both in its apo form and complexed with
its bile-salt activator. These structures provide insight into
the enzymatic mechanism of BAL.
Results and discussion 
Overall structure
The crystal structure of bovine BAL was determined in
both the presence and the absence of taurocholate (TC), a
bile-salt activator of the enzyme. The crystal of apo-BAL
belongs to space group P3121 with one BAL molecule per
asymmetric unit, while the BAL–TC complex belongs to
space group P21212 with two BAL molecules per asym-
metric unit. The current structure of the apoenzyme con-
tains 547 amino acid residues, including the entire bovine
BAL polypeptide chain except the C-terminal 32 residues.
The latter region lacks interpretable electron density. For
the same reason, the structure of the complex contains 532
residues in each of the two BAL molecules. Other than
their C-tails, the conformation of the three BAL molecules
observed in the two crystal forms are essentially the same.
The coordinate root mean square deviations (rmsd) are
0.65 Å and 0.66 Å, for 522 Ca atoms between the apo-
enzyme structure and each of the two BAL molecules in
the BAL–TC complex crystal, and 0.30 Å for 532 Ca
atoms between the two BAL molecules in the BAL–TC
complex crystal.
The dimensions of the N-terminal catalytic domain of
bovine BAL are ~50 Å · 70 Å · 70 Å. The structure con-
sists of 13 b strands and 14 a helices (Figure 1), as
assigned by the Kabsch and Sander algorithm [25], and
bears the characteristic structural features of the a /b hydro-
lase fold family. Eleven b strands (b 2, b 3, and b 5–b 13), form
one b sheet that has a topology (+1, +1, +2, –1x, +2x,
(+1x)4, +1) [26]. Strands b 1, b 4 and the N-terminal part of
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Figure 1
Ribbon diagram of the overall folding of bovine bile salt activated lipase
(BAL), drawn with the programs MOLSCRIPT [41] and Raster3D [42].
a Helices are shown in red, b strands in blue, and coiled-coil in yellow.
The secondary structure assignment was generated using the Kabsch
and Sander algorithm [25] (the names used for the corresponding
secondary structure elements in the GCL crystal structure are given in
parentheses [14]): b 1 = 4–8 (b1), b 2 = 11–20 (b 2 and b 0), b 3 = 25–33
(b 1), b 4 = 53–57 (b3), b 5 = 81–89 (b 2), b 6 = 98–104 (b 3),
b 7 = 137–142 (b 4), b 8 = 187–193 (b 5), b 9 = 215–220 (b 6),
b 10 = 311–318 (b 7), b 11 = 412–419 (b 8), b 12 = 496–501 (b 9),
b 13 = 509–513 (b 10), a A = 127–135 (a 3,4), a B = 146–151,
a C = 161–178 (a 24,5), a D = 194–206 (a 5,6), a E = 232–244 (a 16,7),
a F = 251–261 (a 26,7), a G = 262–269 (a 36,7), a H = 321–329 (a 17,8),
a I = 340–352 (a 27,8), a J = 355–368 (a 37,8), a K = 377–407 (a 47,8),
a L = 438–444 (a 18,9), a M = 454–475 (a 28,9), and a N = 515–529 (a 10).
The N and C termini are labeled. The active site Ser194 is located
between b 8 and a D.
b 2 form a smaller b sheet which may be considered an
extension of the main b sheet. A 31-residue helix, a K,
kinks at position 393 with an angle of 40° forming be-
tween the axes of the two pieces. This kink is also ob-
served in the crystal structure of TAChE, and is associated
with a proline residue (Pro396 in bovine BAL) which
breaks the otherwise continuous hydrogen-bonding pat-
tern within the helix. Helices a I, a J, and a N, together with
the N-terminal part of a K before its kinking point, form a
relatively isolated helix-bundle domain. Between the main
body of the protein and this small domain there is a deep
depression which is ~10 Å deep, 10 Å wide, and 20 Å long.
A coiled-coil loop, residues 270–285, occupies a part of the
depression that might otherwise serve as an exit from the
active site to the depression. A similar, yet smaller, depres-
sion in the crystal structure of the CCE–linoleate complex
was proposed as a possible pathway for releasing the prod-
uct from the catalytic site [19]. 
Four of the five cysteine residues in bovine BAL form two
disulfide bridges which are conserved in the lipase/
esterase family. The first disulfide bridge (Cys64–Cys80)
provides the base for a short loop which is a truncated
version of the interfacial activation lid in other lipases
[12,17]. The second disulfide bond (Cys242–Cys257) fixes
the relative position between two surface helices, a E and
a F. In addition, two salt bridges in the BAL structure,
Arg144–Asp166 and Asp390–Arg515, are among those con-
served in the lipase/esterase family [21]. Arg144–Asp166 is
the most conserved salt bridge in this family, linking the
short loop between b 7 and a B to the helix a C. Both of the
participating residues are almost completely inaccessible
to the solvent (100% and > 90% inaccessible, respec-
tively). The other conserved salt bridge, Asp390–Arg515,
ties the N terminus of the last a helix of the catalytic
domain, a N, to the kinking point of the long helix a K. In
TAChE it was shown that a substitution of the corre-
sponding aspartic acid residue with an asparagine residue
eliminates the catalytic activity of the enzyme [27]. As
the aspartic acid residue is not located in the vicinity of
the active site, this salt bridge presumably contributes to
the catalytic activity by stabilizing the aforementioned
helix-bundle domain and thereby the putative product
releasing channel.
Unlike other lipases which have interfacial activation lids
(that are 25–45 residues long) [12,17], BAL has a shorter
(15 residues long) and, therefore, more rigid loop at the
corresponding position between the disulfide bonded
Cys64 and Cys80 (Figure 2). This loop in BAL can neither
block the entrance of the active site, nor be sufficiently
flexible to switch its conformation. In all three structures
of bovine BAL from the two crystal forms, this loop
possesses a well defined and consistent electron density,
suggesting a relatively rigid conformation. 
The analysis of electrostatic charge distribution on the
molecular surface of bovine BAL revealed two clusters of
positively charged residues, located in the N-terminal and
C-terminal regions, respectively. The N-terminal cluster
comprises Lys31, Lys56, Lys58, Lys61, Lys62, and Arg63,
which are conserved residues among all known mam-
malian BALs but are not conserved in TAChE. The C-
terminal cluster consists of residues Lys336, Arg423,
Lys429, Arg454, Arg458, Lys462 and Lys503; five out of
the seven basic residues in this cluster are also conserved
in all known BALs. Based on the ability of an N-terminal
proteolytic fragment of human BAL to bind heparin [6],
the sequence stretch BXBXXBBB (where B stands for a
basic residue and X stands for an uncharged residue)
between residues 56 and 63 has been proposed to be
involved in heparin binding. In the crystal structure of
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Figure 2
Stereo view of the structural comparison of
apo-BAL and GCL around their active sites.
The Ca trace of the apo-BAL structure is
shown in magenta; the Ca trace of GCL is
shown in blue. Selected residues from BAL
are labeled in red. Also included are the
catalytic triad residues from the two
structures, which are superimposed with each
other. 
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bovine BAL, the N-terminal cluster of positively charged
residues, including the 56–63 stretch, forms a cationic
‘cradle’ similar to those observed in other heparin-binding
proteins [28,29]. The sidechains of Lys31, Lys56, and
Lys58 lie on one side of the cradle, and the sidechains of
Lys61, Lys62, and Arg63 lie on the other side (Figure 3).
The overall crystal structure of bovine BAL closely resem-
bles those of TAChE [23] and GCL [14]. Although the
residues contributing to the 30% amino acid sequence
identity between bovine BAL and TAChE are mostly
located in the N-terminal half of the catalytic domain, the
three-dimensional structural similarity extends to the en-
tire structure. The coordinate rmsd between bovine BAL
(the apoenzyme crystal) and TAChE is 1.4 Å for 422 Ca
atoms (and 1.8 Å for 466 C a atoms). Likewise, the rmsd is
1.4 Å for 344 C a atoms (and 1.8 Å for 395 C a atoms)
between bovine BAL and GCL.
The active site
The active site of bovine BAL consists of a classical cat-
alytic triad with Ser194 as the nucleophile, His435 as the
proton shuttle, and Asp320 to form the charge-relay net-
work. These three residues are conserved in all known
BALs from different species [8]. The sequential order and
spacial arrangement of the catalytic residues are among the
most conserved structural features in the a /b hydrolase
fold family. The nucleophilic serine in BAL is located in
the nucleophile elbow [20] which forms a sharp g -like turn
at the end of strand b 8. As with the nucleophilic residues in
other members of the a /b hydrolase fold family, Ser194 in
BAL possesses a backbone f ,y angle of (56° ,–129° ) which
is located within a less favorable zone of the Ramachan-
dran plot. A structural alignment focused on the catalytic
site shows that, of the 28 Ca atoms that are within 10.0 Å
distance from the Ca atom of Ser194 of BAL, 27 atoms can
superimpose on the corresponding atoms in TAChE with a
coordinate rmsd of less than 0.5 Å.
In addition to the conserved catalytic triad, there are
several partially buried acidic residues around His435,
including Glu193, Asp434, Asp437, and Asp438. The func-
tion of these residues are presumably to enhance the
capacity of His435 to shuttle protons. These residues are
also conserved in all known members of the BAL family.
In the crystal structure of TAChE, residue 199 (corre-
sponding to Glu193 in BAL) is conserved, and residue 443
(corresponding to Asp438 in BAL) is conservatively substi-
tuted by a glutamate residue.
Near the catalytic site, the backbone amide groups of the
residues 107 and 108 are both less than 5 Å away from the
Og atom of Ser194. These groups, together with the amide
group of Ala195, form a putative oxyanion hole to stabilize
the tetrahedral transition state of the substrate during the
catalysis [20]. Unlike many ‘true’ lipases in which the
oxyanion hole is formed by a conformational rearrange-
ment of the active-site loop during water–lipid interfacial
activation [12], the oxyanion hole of BAL is correctly
formed in the apoenzyme crystal structure and is presum-
ably functional. A comparison of the structure of apo-BAL
around the active site with that of GCL in its closed form
is shown in Figure 2. 
Two bile salt binding sites 
Two bile salt molecules are found in each BAL molecule
in the BAL–TC complex crystal. The first one binds near
the active site (Figure 4); the second binds in a depression
region on the back side of the catalytic domain of the
enzyme remote from the active site (Figure 5). 
The loop region, residues 116–124, appears to be important
for the binding of the first, active-site proximal, bile salt
molecule. Studies on the primary sequences of enzymes in
the lipase/esterase family revealed that all known BALs
contain a unique segment of consensus sequence GAN-
FLXNYLYDGEE (where X is variable) in the region of
residues 116–129. The first few residues of this segment
form a BAL-specific insert, relative to other members in the
lipase/esterase family [8]. While residues 125–129 form the
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Figure 3
GRASP [43] representation of the molecular surface of the BAL–TC
complex. The TC molecule is shown as a  yellow space-filling model.
The residues involved in the dimerization are colored in pink and
selectively labeled; charged and polar residues are colored in purple
and hydrophobic residues in white. The active-site nucleophile,
Ser194, is surrounded by a hydrophobic surface area. The region
labeled with ‘HB’ is the putative heparin-binding ‘cradle’; two rows of
positively charged residues align on the left and right sides of the
marked region. 
N terminus of the helix a A and have a well-defined electron
density, the conformation of the preceding loop region
appears to be dependent on bile-salt binding. In the apoen-
zyme crystal, there is a substantial, yet discontinuous, elec-
tron density in the region between residues 116 and 124,
indicating that this region is flexible when bile salt is
absent. Based on the pieces of equivocal electron density,
the conformation of this region was modeled in apo–BAL as
a hairpin loop with its tip (i.e. the sidechain of Phe119) less
than 5 Å from the Og atom of the nucleophilic Ser194. In
this putative conformation, the entrance of the active site is
almost completely blocked by the loop (Figure 4). A super-
position of this BAL structure on that of the CCE–linoleate
complex [19] revealed that the cholesterol moiety of the
substrate in the CCE complex and the BAL-specific loop
occupy the same position in the homologous structures.
This observation suggests that the loop must move away in
order for a substrate to enter the active site. Indeed, such a
conformational change was confirmed by the BAL–TC
complex crystal structure. In this structure, the electron
density of the BAL-specific loop (residues 116–124) is well
defined, revealing a new and more open conformation
(Figure 4). The tip of the loop, protruding from the protein
surface, is more than 20 Å away from Ser194. 
The active-site proximal bile salt binding site is located
between the BAL-specific loop in its open conformation
and the region of residues 445–453. The structure of the
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Figure 4
Stereo view of the active-site proximal bile salt
binding site in bovine BAL. The Ca trace of
the apo-BAL structure around the active site
is colored in magenta; the Ca trace of the
BAL molecule in the BAL–TC complex is
colored in blue. Also included are the catalytic
triad and the active-site proximal TC molecule.
Ca atoms of the entire polypeptide chain,
except the 116–124 loop region and the C-
tail region, were used in the structure
superposition. The BAL molecule is in
approximately the same orientation as in
Figure 1. The conformational change of the
116–124 loop is shown.
115 115 
S194 S194 
108 108 
H435 H435 
D320 D320 
285 285 
TC TC 
   120    120
120 120 
450 450 
75 75 
 270  270 70 70 
425 425 
 330  330 
335 335 
Figure 5
Stereo view of the active-site distal bile salt
binding site in bovine BAL. This site is located
in the cleft between the small helix-bundle
domain (on the right-hand side) and the main
body of the catalytic domain (on the left-hand
side). A 2.8 Å (Fobs–Fcalc) omit map (blue), in
which the two active-site distal TC molecules
are deleted from phase calculation, is
superimposed on the Ca trace of the BAL
structure (magenta). The electron-density map
is contoured at 3.5 standard deviation. The
His283 sidechain and the active-site distal TC
molecule are also shown as stick models.
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latter region appears rigid in both apo-BAL and the
BAL–TC complex structures. This TC-binding position
presumably stabilizes the open conformation of the BAL-
specific loop. The TC molecule is positioned such that its
3 a hydroxyl group is hydrogen bonded to the backbone
amide group of residue 124 in the BAL-specific loop, and
its 7 a hydroxyl group is hydrogen bonded to the Og 1 atom
of Thr449. In the BAL–TC complex structure, the active
site of the BAL molecule is located at the bottom of a
hydrophobic and accessible surface depression (Figure 3).
A substrate model of cholesterolester can fit nicely into
this surface depression.
In the BAL–TC complex crystal structure, a second TC
molecule was found remote from the active site. This
binding site is in the cleft between the small helix-bundle
domain and the main body of the enzyme (see the overall
structure section and Figure 5). This site is essentially
empty in the bile salt free crystal, although some weak
electron density is seen inside this cleft, suggesting the
presence of some disordered water molecules when bile
salt is absent. The observation of the second bile salt
binding site is consistent with some previous data which
suggested that BAL may have two bile salt binding sites
[30]. However, unlike the active-site proximal bile salt
binding site, a comparison of the structures of apo-BAL
and the BAL–TC complex shows no obvious conforma-
tional change associated with the second binding site.
This lack of structural response and the distal location
from the active site seems to suggest that this second bile
salt binding site is unrelated to the catalytic process itself.
It remains unclear as to whether there is a biological func-
tion for this binding site.
In the proximal and distal binding sites, the TC mol-
ecules are orientated in such a way that their sulfate
groups are close to the sidechains of His322 and His283,
respectively. Both of these histidine residues are con-
served in all known mammalian BALs. In contrast to
previous proposals [8], no arginine residue was found in
direct contact with any part of the TC molecule, includ-
ing its anionic group. 
BAL dimerization
The packing arrangements of BAL molecules in both
crystal forms are consistent with dimer formation. In the
apo-BAL structure, there is only one potential dimeriza-
tion interface related by a crystallographic twofold axis.
The two BAL molecules have their active sites facing
each other. Only about 1% (~ 400 Å2) of the total solvent-
accessible surface [31] from the two monomers is buried in
this dimer interface, arguing that the interaction between
the two symmetry-related BAL molecules may not be
biologically relevant. A molecular dimer also occurs in the
BAL–TC complex structure, in which the two BAL mol-
ecules of a crystallographic asymmetric unit again form a
face-to-face dimer. The two BAL molecules are related by
a pseudo-twofold symmetry of a 172° rotation. The two
dimer forms are therefore related but not identical.
The interaction at the dimer interface in the BAL–TC
complex crystal is more extensive than that observed in
the apoenzyme crystal (Figures 3 and 6). The two short-
ened loops between the disulfide bonds, Cys64–Cys80,
are located at one end of the pseudo-twofold axis (i.e. the
front of Figure 6) and the two loops of residues 423–429
(with a 6 Å Ca –Ca distance between the two Pro425
residues) are located at the other end of the axis (i.e. the
back of Figure 6). The dimer architecture produces a
cavity between the two face-to-face active sites. The Ca –
Ca distance between the two catalytic serine residues is
~40 Å. Within the dimer interface, there exist several
holes. The active-site proximal TC molecules are located
within the cavity and are involved in the dimer formation.
For each of these two TC molecules, the nonpolar region
of the molecule binds with the BAL-specific loop (i.e.
residues 116–124) in one monomer while its anionic group
contacts with helix a H (residues 321–329) of the other
monomer. On the outside surface of the dimer are the
active-site distal bile salt binding sites, potential N-glyco-
sylation sites and the C-tail regions of BAL. In addition,
on the outside surface there are two clusters of positively
charged residues located close to each of the two poles of
the pseudo-twofold axis. One of these clusters consists of
the two putative heparin-binding sites formed by the
stretches of residues 56–63. The other cluster consists of
seven positively charged residues (Lys336, Arg423, Lys429,
Arg454, Arg458, Lys462, and Lys503) from each mono-
mer, which are aligned on the edge of the interface. This
arrangement of two rows of positively charged residues
parallel to each other on the dimer surface seems to be
energetically unfavorable, but may, on the other hand,
facilitate the binding of micelles to BAL.
About 1 200 Å2 of the solvent-accessible surface area (i.e.
3% of the total) [31] from the two monomers is buried in
the dimer interface upon binding bile salt (Figure 3).
Neither salt bridges, hydrogen bonds, nor substantial
complementary surface area was found between the two
BAL monomers. This observation suggests that the dimer
may only be moderately stable and dictates that caution
should be used in establishing the functional roles of the
BAL dimer. 
Dimerization with an architecture of face-to-face active
sites and a hydrophobic central cavity has been observed
in several crystal structures of enzymes in the lipase/
esterase family, including CRL in its open form [17] (but
not the close form [18]), and CCE complexed with choles-
terolester molecules [19]. For both CRL and CCE, as in
the BAL–TC crystal structure, about 5% of the surface
area of the enzyme is buried in the dimer interface. A
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detailed structural comparison of these enzymes shows
that the type of dimer interaction and the relative orienta-
tion of the two monomers is quite different from one
dimer to another. For example, at the interface of the
CCE dimer, two antiparallel strands form four hydrogen
bonds between the two monomers, as compared with the
mainly van der Waals interactions at the corresponding
position in the BAL–TC complex structure. When one
monomer in the BAL–TC complex crystal is superim-
posed on one CCE monomer, it requires an ~90° rotation
and an ~10 Å center–center translation to accomplish
superposition of the other pair of monomers. The corre-
sponding rotation and translation between the symmetry-
related BAL dimer in the apoenzyme crystal and the BAL
dimer observed in the complex crystal are 50° and 13 Å,
respectively. Although it has long been proposed [30] that
dimerization may play a role in the bile-salt activation of
BAL, the current structural evidence does not necessarily
lend support to this hypothesis. The activation of BAL by
bile salt is more likely to be a result of binding to the loop
near the active site, which may be independent of the
dimerization. BAL dimers observed in the crystals may
also occur in solution simply to keep the hydrophobic
surface of the enzyme away from aqueous solution, as in
other lipases. Functionally, however, because of the insol-
ubility of the lipid substrates, the accessibility of the sub-
strate in lipid droplets to the active site of the BAL dimer
would be extremely poor.
N-glycosylation sites
BALs from human, rat, cow, rabbit and salmon all contain
a conserved potential N-glycosylation site at Asn187 (num-
bered as in bovine BAL). In all three BAL molecules of
the two crystal forms, however, the electron density was
absent beyond the sidechain of Asn187. Particularly in
the apoenzyme crystal, several sidechains from a symme-
try-related neighboring protein molecule have loose con-
tacts with Asn187, indicating that Asn187 is unlikely to be
N-glycosylated. Another potential N-glycosylation site is
at Asn361. Whilst this sidechain is also solvent-exposed, it
is not involved in any crystal contacts in either crystal
form. The most definitive glycosylation is observed in the
BAL–TC complex structure, in which one of the BAL
molecules has a well defined electron density for the first
N-acetylglucosamine unit connected to Asn361 (but there
is no interpretable electron density beyond it). These
observations are consistent with the results of experi-
ments using CNBr digestion and mass spectroscopy,
which showed that in bovine BAL the Asn187 site is not
glycosylated but Asn361 is N-glycosylated (C-SW et al.,
unpublished data).
The flexible C-terminal tail
In addition to the catalytic domain, BAL molecules
usually contain a proline-rich C-terminal region (C-tail) of
various lengths. In human BAL, the C-tail is clearly com-
prised of 16 repeats of a consensus motif PVPPTGDS-
GAP [1]. As the C-tail is both proline-rich and often
highly O-glycosylated, not to mention its variable length
in BALs from different species, this region is unlikely to
have a regular, globular conformation. Bovine BAL has a
C-tail (residues 530–579) equivalent to three repeats of
the consensus motif [1]. In contrast to human BAL, the
C-tail in bovine BAL is not glycosylated (C-SW et al.,
unpublished data).
For both BAL molecules in the BAL–TC complex crystal,
the C-tails are completely invisible in the electron-density
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Figure 6
Stereo view of the dimer of BAL complexed
with TC molecules. The pseudo-twofold axis is
perpendicular to the plane of the drawing. The
BAL dimer of the BAL–TC complex crystal is
presented in blue ribbon representation; the
TC molecules are shown as red space-filling
models. The N and C termini are labeled as N
and C, respectively. The active-site proximal
bile salt binding site is located within the
central cavity between the two monomers,
whilst the active-site distal binding site is on
the outside surface of the dimer.
map beyond residue 532. In the apo-BAL crystal struc-
ture, the electron density of the C-tail is partially visible
in the region of residues 530–547 and appears as a con-
nected, but featureless, tube in which the peptide back-
bone can fit. Beyond that point, the last 32 residues of the
C-tail can be accommodated in the crystal lattice without
affecting the structure of either the rest of the protein or
symmetry-related neighboring BAL molecules. However,
this part of the C-tail completely lacks interpretable elec-
tron density, indicating that it is flexible relative to the
catalytic domain. The beginning of the C-tail (ca.
residues 530–547) is trapped in a crystal-contact cleft
between its own catalytic domain and a neighboring BAL
molecule. This observation provides an explanation for
the better visibility of this fragment than that of the rest
of the C-tail. The visible part of the C-tail was modeled
in a more or less extended conformation. No a helix or
b sheet hydrogen-bonding network can be identified
within the C-tail or with the rest of the protein. Consis-
tent with proteolysis and mass spectroscopy studies on
bovine BAL, no O-glycosylation is detected around the
visible region of the C-tail.
Biological implications 
Bile salt activated lipase (BAL) is secreted from the pan-
creas into the intestine in adult mammals. In infants of
humans and a few other mammals, BAL is also supplied
by the mother’s milk. Although BAL shares with other
intestinal lipases the hydrolytic activity for triacylglycerol,
it is the only intestinal enzyme that hydrolyzes cholesterol
and vitamin A esters. The absolute dependence of BAL
activity on bile salts is also unique among the lipases and
is especially important for human infant nutrition. The
bile salt dependence renders the high concentration of
BAL in the mother’s milk inactive until it reaches the
intestine where bile salt is located. BAL also binds
heparin, which is independent of the enzymatic activity.
The primary structure of BAL, although homologous to
those of acetylcholine esterase and cholesterol esterase,
contains a unique proline-rich C-terminal region which
contains varying numbers of repeats of a consensus
sequence and different glycosylation patterns for the
enzymes from different species of mammals.
The crystal structures of BAL presented here permit a
better understanding of the broad substrate specificity
and bile-salt activation of this enzyme. Comparison of
the apoenzyme and the bile salt (taurocholate)-bound
structures of BAL shows that there is a conformational
change of a short loop (residues 116–124) near the
active site as a result of the binding of a taurocholate
molecule. This bile-salt triggered conformational change
opens the active site allowing the access of substrates.
The open conformation of the short loop provides suffi-
cient room to accommodate a variety of substrates. This
process is similar to the structural changes which occur
in the activation of other lipases by a water–lipid
interface. The current structural information, therefore,
provides a logical explanation as to the unique activation
mechanism of BAL. 
Additional biological insights may also be derived from
three other structural features of the BAL crystal struc-
tures. Firstly, it has previously been thought that the
active form of BAL is the dimer. If so, the bile salt-
bound BAL dimer observed in the crystal structure may
contain structural information to suggest a mechanism
for substrate transportation into and binding within the
internal cavity of the dimer. Secondly, the absence of a
definitive conformation of the C-terminal region of BAL
is important for explaining the biological role of this
region. Although the C-terminal region of the bovine
enzyme has only three consensus repeats, its structure is
nevertheless a model for BAL of other species. Human
BAL, for example, has 16 repeats and a highly glycosy-
lated C-terminal region. The conformational flexibility
of the C-tail observed in the two crystal forms, and its
location relative to the active site, suggest that the C-tail
is unlikely to participate in the substrate binding and
activation mechanism. Thirdly, the proposed location of
the heparin-binding site of BAL, based on the crystal
structure, has no structural overlap with the catalytic
site, which is consistent with the independence of BAL
activity from heparin binding. However, the location of
the site does not exclude the possibility of BAL
involvement in other physiological functions, such as the
suggested association of BAL to cellular surfaces
through its heparin-binding site. 
Materials and methods
Protein purification and crystallization
Bovine bile salt-activated lipase was purified from bovine pancreas. A
detailed procedure of purification and crystallization will be described
elsewhere (C-SW et al., unpublished data). Briefly, bovine pancreatic
tissue was homogenized in 0.1 M sodium acetate buffer, pH 5.1 and the
supernatant filtered and precipitated with ammonium sulfate. The sample
was resuspended and subjected to ion-exchange chromatography, cho-
late-sepharose affinity chromatography and molecular sieving chromatog-
raphy. The best crystals were grown from hanging drops at 20° C by
mixing the protein of ~25 mg/ml with an equal volume of well solution
containing 1.8 M ammonium sulfate, 5% isopropanol and additives. The
additives consist of 1 mM zwittergent 3-12 for the apo-BAL crystal, or
1 mM TC plus 0.1 mM sucrose monolaurate for the BAL–TC complex
crystal. The apo-BAL crystal grew to its full size of ~0.3 mm · 0.3 mm ·
0.8 mm in one week, while the complex took about 2–4 weeks to grow to
a size of ~0.1 mm · 0.2 mm · 0.4 mm.
Data collection
X-ray diffraction data of the apo-BAL crystal were collected at room
temperature using mirror-focused CuKa radiation from a Rigaku RU-
200 rotating-anode source and an RAXIS II image plate detector
system. The space group is P3121 (or P3221), based on data autoin-
dexed and processed with the program suite HKL [32] and also based
on the manual inspection of systematic absences. There is one bovine
BAL molecule per asymmetric unit with VM = 2.9 Da/Å3 [33]. Although
a fresh crystal diffracted up to 2.4 Å resolution, the crystal was sensi-
tive to X-ray radiation damage. A usable data set of resolution range
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from 30.0 to 2.8 Å was collected. The X-ray diffraction data for the
BAL–TC complex crystal were collected on a Siemens multiwire area
detector. The crystal diffracted up to 2.8 Å in both the a and c direc-
tions and to only 3.5 Å in the b direction. Because of the anisotropic
thermal property of the crystal, a 1.5 standard deviation cut-off was
used in the data reduction mainly to eliminate weak reflections along
the b direction. A data set of 83% completeness in the 17.0–2.8 Å
shell was collected with an Rmerge of 0.117. The programs SADIE and
SAINT (Siemens program package) were used in the data reduction.
This crystal form belongs to the P21212 space group. 
Structure analysis
Molecular replacement study of the apo-BAL crystal structure was
carried out using the program MRCHK [34] and the crystal structure of
TAChE (PDB code 1ACE) [23] as the homologous search model. All
of the backbone atoms including Cb atoms as well as the sidechains of
those identical residues between BAL and TAChE were included in the
search model. A rotation function search with 10.0–4.5 Å resolution
data and 30 Å integration radius showed a top peak that was 1.3
standard deviation higher than the next one. A subsequent translation
function search with 10.0–4.0 Å resolution data identified the space
group to be P3121 and resulted in a solution that was more significant
by 0.6 standard deviation than the next peak. This molecular replace-
ment solution showed a good crystal packing. Rigid-body refinement
with the program TNT [35] reduced the R factor from 0.54
(20.0–4.0 Å) to 0.49 (20.0–3.2 Å), suggesting that the solution was
correct. The solution was further confirmed with a series of (Fobs–Fcalc)
omit maps, in each of which a small fragment of the peptide (~10
residues) was omitted from the phase calculation. The sizes and
shapes of a significant number of sidechains of amino acid residues
were able to be recognized in the omit map. On the other hand, the
initial (2Fobs–Fcalc) map contained regions of poorly defined electron
density, mostly corresponding to the insertion/deletion found in a
sequence alignment between bovine BAL and TAChE. The structure
was built and refined through alternative cycles using the programs O
[36] and X-PLOR [37]. The free R factor [38] was monitored during
the refinement using a 10% test set randomly chosen from the
observed data. At the final stage of refinement, the program TNT was
used to carry out a restrained temperature-factor refinement. No
attempt was made to explicitly include solvent molecules in the model.
The crystal structure of the BAL–TC complex was solved using molecu-
lar replacement methods and the apo-BAL crystal structure as the search
model. There are two BAL molecules in one asymmetric unit with
VM = 3.2 Da/Å3. The molecular replacement search was straight forward
and resulted in a model of initial R factor of 0.41 (15.0–4.0 Å). As the
complex crystal diffracted very anisotropically, an anisotropic B factor
correction was applied to Fobs. The refinement procedure was similar to
that of the apo-BAL crystal, with additional noncrystallographic symmetry
restraints at the beginning. Averaged electron-density maps were used
as references throughout model building to compensate the lack of com-
pleteness of the data set.
Statistics of the data collection and the refinement are listed in
Table 1. The consistency of the protein geometry was validated using
PROCHECK [39]. All of the backbone f , y torsional angles were
located within the allowed region in the Ramachandran plot, with
80% in the most favored regions for both the apo-BAL and the
complex structures. The position and orientation of the TC molecules
were confirmed with an (Fobs–Fcalc) omit map in which the bile salt
molecules had been deleted from the phase calculation. Electron-
density peaks of seven to nine standard deviation were observed at
the positions of sulfate groups of the putative TC molecules. Struc-
tural analysis, including an automated three-dimensional structural
alignment and calculation of solvent-accessible area [31], was carried
out with the program EDPDB [40]. A 1.4 Å probe radius was used for
all solvent-accessible area calculations. The coordinates of GCL (PDB
code 1THG) [14], CCE (1CLE) [19] as well as TAChE (1ACE) [23]
were used in the structural comparison.
Accession numbers
Coordinates of both the apoenzyme and BAL–TC complex have been
deposited in the Protein Data Bank at Brookhaven, with accession
codes 1AKN and 1AQL, respectively.
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